Researchclopedia
Research
Researchers
Institutions
Topics
Submit
About
Search...
⌘
K
Command Palette
Search for a command to run...
Back to research
WCN26-3778 MECHANISTIC EFFECTS OF SEMAGLUTIDE ON KIDNEY DISEASE IN TYPE 2 DIABETES: THE REMODEL TRIAL
2026
0 citations
Journal Article
gold Open Access
Field-Weighted Citation Impact:
0.00
·
Novo Nordisk (India)
Vivek Das
·
Novo Nordisk (Denmark)
Thomas Idorn
·
Novo Nordisk (Denmark)
Philip Andreas Schytz
·
Novo Nordisk (Denmark)
Matthias Kretzler
·
University of Michigan
WCN26-3778 MECHANISTIC EFFECTS OF SEMAGLUTIDE ON KIDNEY DISEASE IN TYPE 2 DIABETES: THE REMODEL TRIAL | Researchclopedia